btk degrader abbv-101 vs anti-cd71/vcmmae probody-drug conjugate cx-2029
| btk degrader abbv-101 | anti-cd71/vcmmae probody-drug conjugate cx-2029 | |
|---|---|---|
| Developers | 0 | 0 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | BTK Degrader ABBV-101 | Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029 |